Linked Life Data

20308463

Source:http://linkedlifedata.com/resource/pubmed/id/20308463

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20308463rdf:typepubmed:Citationlld:pubmed
pubmed-article:20308463lifeskim:mentionsumls-concept:C0221287lld:lifeskim
pubmed-article:20308463lifeskim:mentionsumls-concept:C0221464lld:lifeskim
pubmed-article:20308463lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:20308463lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:20308463lifeskim:mentionsumls-concept:C1514474lld:lifeskim
pubmed-article:20308463lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:20308463lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:20308463lifeskim:mentionsumls-concept:C0796679lld:lifeskim
pubmed-article:20308463lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:20308463pubmed:issue1lld:pubmed
pubmed-article:20308463pubmed:dateCreated2010-3-23lld:pubmed
pubmed-article:20308463pubmed:abstractTextTo evaluate the clinical effectiveness of transcatheter arterial chemoembolization (TACE) performed in patients with nonresectable combined hepatocellular carcinoma (HCC) and cholangiocarcinoma and analyze the prognostic factors of patient survival after TACE.lld:pubmed
pubmed-article:20308463pubmed:languageenglld:pubmed
pubmed-article:20308463pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20308463pubmed:citationSubsetAIMlld:pubmed
pubmed-article:20308463pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20308463pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20308463pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20308463pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20308463pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20308463pubmed:statusMEDLINElld:pubmed
pubmed-article:20308463pubmed:monthAprlld:pubmed
pubmed-article:20308463pubmed:issn1527-1315lld:pubmed
pubmed-article:20308463pubmed:authorpubmed-author:SongHo-YoungH...lld:pubmed
pubmed-article:20308463pubmed:authorpubmed-author:YoonHyun-KiHKlld:pubmed
pubmed-article:20308463pubmed:authorpubmed-author:SungKyu-BoKBlld:pubmed
pubmed-article:20308463pubmed:authorpubmed-author:ShinJi HoonJHlld:pubmed
pubmed-article:20308463pubmed:authorpubmed-author:KoGi-YoungGYlld:pubmed
pubmed-article:20308463pubmed:authorpubmed-author:KimJin...lld:pubmed
pubmed-article:20308463pubmed:authorpubmed-author:GwonDong IlDIlld:pubmed
pubmed-article:20308463pubmed:authorpubmed-author:JangCheol...lld:pubmed
pubmed-article:20308463pubmed:copyrightInfoRSNA, 2010lld:pubmed
pubmed-article:20308463pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20308463pubmed:volume255lld:pubmed
pubmed-article:20308463pubmed:ownerNLMlld:pubmed
pubmed-article:20308463pubmed:authorsCompleteYlld:pubmed
pubmed-article:20308463pubmed:pagination270-7lld:pubmed
pubmed-article:20308463pubmed:meshHeadingpubmed-meshheading:20308463...lld:pubmed
pubmed-article:20308463pubmed:meshHeadingpubmed-meshheading:20308463...lld:pubmed
pubmed-article:20308463pubmed:meshHeadingpubmed-meshheading:20308463...lld:pubmed
pubmed-article:20308463pubmed:meshHeadingpubmed-meshheading:20308463...lld:pubmed
pubmed-article:20308463pubmed:meshHeadingpubmed-meshheading:20308463...lld:pubmed
pubmed-article:20308463pubmed:meshHeadingpubmed-meshheading:20308463...lld:pubmed
pubmed-article:20308463pubmed:meshHeadingpubmed-meshheading:20308463...lld:pubmed
pubmed-article:20308463pubmed:meshHeadingpubmed-meshheading:20308463...lld:pubmed
pubmed-article:20308463pubmed:meshHeadingpubmed-meshheading:20308463...lld:pubmed
pubmed-article:20308463pubmed:meshHeadingpubmed-meshheading:20308463...lld:pubmed
pubmed-article:20308463pubmed:meshHeadingpubmed-meshheading:20308463...lld:pubmed
pubmed-article:20308463pubmed:meshHeadingpubmed-meshheading:20308463...lld:pubmed
pubmed-article:20308463pubmed:meshHeadingpubmed-meshheading:20308463...lld:pubmed
pubmed-article:20308463pubmed:meshHeadingpubmed-meshheading:20308463...lld:pubmed
pubmed-article:20308463pubmed:meshHeadingpubmed-meshheading:20308463...lld:pubmed
pubmed-article:20308463pubmed:meshHeadingpubmed-meshheading:20308463...lld:pubmed
pubmed-article:20308463pubmed:meshHeadingpubmed-meshheading:20308463...lld:pubmed
pubmed-article:20308463pubmed:meshHeadingpubmed-meshheading:20308463...lld:pubmed
pubmed-article:20308463pubmed:meshHeadingpubmed-meshheading:20308463...lld:pubmed
pubmed-article:20308463pubmed:meshHeadingpubmed-meshheading:20308463...lld:pubmed
pubmed-article:20308463pubmed:meshHeadingpubmed-meshheading:20308463...lld:pubmed
pubmed-article:20308463pubmed:year2010lld:pubmed
pubmed-article:20308463pubmed:articleTitleNonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization.lld:pubmed
pubmed-article:20308463pubmed:affiliationDepartment of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Poongnap-dong, Songpa-gu, Seoul 138-736, Republic of Korea. m1fenew@daum.netlld:pubmed
pubmed-article:20308463pubmed:publicationTypeJournal Articlelld:pubmed